STRATA CRITICAL MEDICAL, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$30.87 million for the 9-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Income Statement
us-gaap:ProfitLoss · last filed 2021-08-16
- STRATA CRITICAL MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2021-03-31 was -$1.08M, a 118.97% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-12-31 was -$20.99M.
- STRATA CRITICAL MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-09-30 was -$100.16K.
- STRATA CRITICAL MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-06-30 was -$5.13M.
- STRATA CRITICAL MEDICAL, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$20.52M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 1 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 4 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 7 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 7 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | -$30.87M 10-Q · filed 2021-08-16 | |||||||||
| 2021-03-31 | -$1.08M 10-Q · filed 2021-05-24 | -$22.07M derived: sum of 2 quarters · filed 2021-05-24 | -$22.17M derived: sum of 3 quarters · filed 2021-05-24 | -$27.30M derived: sum of 4 quarters · filed 2021-05-24 | ||||||
| 2020-12-31 | -$20.99M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-07 | -$21.09M derived: sum of 2 quarters · filed 2021-05-07 | -$26.22M derived: sum of 3 quarters · filed 2021-05-07 | -$20.52M 10-K/A · filed 2021-05-07 | $127.72K 10-K · filed 2021-03-10 | |||||
| 2020-09-30 | -$100.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$5.23M derived: sum of 2 quarters · filed 2020-11-10 | $465.93K 10-Q · filed 2020-11-10 | |||||||
| 2020-06-30 | -$5.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $566.09K 10-Q · filed 2020-08-13 | -$9.45M 10-Q · filed 2021-08-16 | |||||||
| 2020-03-31 | $5.70M 10-Q · filed 2021-05-24 | $572.07K 10-Q · filed 2020-05-13 | ||||||||
| 2019-12-31 | $2.33M 10-K/A · filed 2021-05-07 | $784.78K 10-K · filed 2020-03-20 | ||||||||
| 2019-09-30 | $98.14K 10-Q · filed 2020-11-10 | |||||||||
| 2019-06-30 | -$1.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |